Estimate Oftherapeutic Effect of Ditranolbyapplying High Frequencyultrasound in Psoriasis Patients

Psoriasis is chronic dermatosis with the prevalence of 1-2% in the general population (1,2). Although it can not be completely cured, there are numerous therapeutic procedures that can lead the patient into remission and allow for it to last a longer period. The basic aim of the treatment is to decrease the activity of the illness and to reduce the spreading of changes to the level that does not significantly influence thework capability, nor does it in any other way hinder the social life of the patient (3-5). The treatment protocols subsume local application of medicines, phototherapy, systemic therapy and the combination of thesemethods (6). For almost an entire century, ditranol (antralin, cignolin) has had an important place in topical psoriasis treatment (7). Applied in the prescribed dose and concentration, it is highly efficient and practically a nontoxic medicine. Antiproliferative effect is expressed through the inhibition of replication and reparation of DNA 1